SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Nasdaq
Börse Nasdaq
ISIN US7599161095
  • Repligen
    Börse Börse München
    Symbol RGN
    EUR
  • Repligen
    Börse Börse Frankfurt
    Symbol RGN
  • Repligen
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol RGN
    EUR
  • Repligen
    Börse Gettex System der Börse München
    Symbol RGN
    EUR
  • Repligen
    Börse Quotrix System der Börse Düsseldorf
    Symbol RGN
    EUR
  • Repligen
    Börse Börse Stuttgart
    Symbol RGN
    EUR
  • REPLIGEN CORP
    Börse Börse Düsseldorf
    Symbol RGN
    EUR
  • REPLIGEN CORP
    Börse Börse Berlin
    Symbol RGN
    EUR
  • Repligen
    Börse Nasdaq
    ISIN US7599161095 WKN: 870980
    Symbol RGEN
  • ISIN US7599161095 WKN: 870980
    Symbol RGEN
    USD
ISIN US7599161095
WKN 870980
Symbol RGEN
Börse Nasdaq Zeitzone: Europe/Berlin
Marktkapitalisierung 10.734.668.064 (+- 15%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

12.380.336.128 oder 9.089.000.000

Mitarbeiter 1.393 (+- 45%)

Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:

761 oder 2.025 Mitarbeiter

KGV 274.25
EBITDA 85.200.000
PEGRatio 2.59
Buchwert 21.383

Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 164,35 EUR -0,45% 

37 News & Informationen zur Repligen Aktie

  • Stocks That Hit 52-Week Highs On Friday
    benzinga.com

    Stocks That Hit 52-Week Highs On Friday

    Before 10 a.m. ET Friday, 183 stocks hit new 52-week highs.
    Areas of Significance: Alphabet (NASDAQ:GOOG) was the biggest firm by market cap …

  • The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology...
    markets.businessinsider.com

    The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…

  • Repligen (RGEN) Up 16.5% Since Last Earnings Report: Can It Continue?
    zacks.com

    Repligen (RGEN) Up 16.5% Since Last Earnings Report: Can It Continue?

    Repligen (RGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Stocks That Hit 52-Week Highs On Thursday
    benzinga.com

    Stocks That Hit 52-Week Highs On Thursday

    Before 10 a.m. ET on Thursday, 91 companies hit new 52-week highs.
    Interesting Points: The largest company by market cap to set a new 52-week …

  • Dynavax (DVAX) Gains as Medigen Rolls Out COVID-19 Vaccine
    entrepreneur.com

    Dynavax (DVAX) Gains as Medigen Rolls Out COVID-19 Vaccine

    Dynavax (DVAX) stock gains as partner Medigen announces launch of its COVID-19 vaccine MVC-COV1901 adjuvanted with CpG 1018 of the former.

  • Whether Growth Or Value Stocks Lead, These Themes Offer Resilient Investments
    forbes.com

    Whether Growth Or Value Stocks Lead, These Themes Offer Resilient Investments

    All year, equities have rotated back and forth between those favoring growth and those favoring value. While these short-term changes can cause confusion about what industry groups to invest in, there are some themes that should do well regardless of whether the market favors growth or value.

  • Stocks That Hit 52-Week Highs On Wednesday
    benzinga.com

    Stocks That Hit 52-Week Highs On Wednesday

    Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs.
    Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market …

  • Stocks That Hit 52-Week Highs On Tuesday
    benzinga.com

    Stocks That Hit 52-Week Highs On Tuesday

    Before 10 a.m. ET on Tuesday, 100 stocks hit new 52-week highs.
    Things to Consider: The largest company by market cap to break to a new …

  • Repligen Stock: Set Recurring Investments To Sleep Well, Help Cure Diseases (NASDAQ:RGEN)
    seekingalpha.com

    Repligen Stock: Set Recurring Investments To Sleep Well, Help Cure Diseases (NASDAQ:RGEN)

    Growth is trending back up from lows over the past three years and margins are expanding nicely as well.

  • After Golden Cross, Repligen (RGEN)'s Technical Outlook is Bright
    zacks.com

    After Golden Cross, Repligen (RGEN)'s Technical Outlook is Bright

    Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?

  • Hanseatic Management Services Inc Buys Vanguard Mid-Cap ETF, VanEck Vectors Semiconductor ETF, iShares Nasdaq Biotechnology Index Fund,...
    gurufocus.com

    Hanseatic Management Services Inc Buys Vanguard Mid-Cap ETF, VanEck Vectors Semiconductor ETF, iShares Nasdaq Biotechnology Index Fund, Sells Vanguard Short-Term Inflation-Protected Securities, Utilit

    GuruFocus Article or News written by insider and the topic is about:

  • Is Ozon Holdings PLC (OZON) A Good Stock To Buy?
    insidermonkey.com

    Is Ozon Holdings PLC (OZON) A Good Stock To Buy?

    In this article we will take a look at whether hedge funds think Ozon Holdings PLC (NASDAQ:OZON) is a good investment right now. We check hedge fund and…

  • Stocks That Hit 52-Week Highs On Thursday
    benzinga.com

    Stocks That Hit 52-Week Highs On Thursday

    Thursday's morning session saw 167 companies set new 52-week highs.
    Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by …

  • Repligen Corp (RGEN) Q2 2021 Earnings Call Transcript
    fool.com

  • A Trio of Highly Profitable Businesses With Solid Financial Conditions
    gurufocus.com

    A Trio of Highly Profitable Businesses With Solid Financial Conditions

    GuruFocus Article or News written by Alberto Abaterusso and the topic is about: They hold high GuruFocus ratings for financial strength and profitability

  • Repligen (RGEN) Q2 Earnings and Revenues Surpass Estimates
    zacks.com

    Repligen (RGEN) Q2 Earnings and Revenues Surpass Estimates

    Repligen (RGEN) delivered earnings and revenue surprises of 49.06% and 12.26%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

  • Repligen shares rise on Q2 earnings beat, FY forecast raise (NASDAQ:RGEN)
    seekingalpha.com

    Repligen shares rise on Q2 earnings beat, FY forecast raise (NASDAQ:RGEN)

    Repligen (RGEN) shares rise nearly 3% premarket after the company posted second-quarter results that beat Wall Street estimates, and raised its full-year forecast.The company's…

  • Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance
    globenewswire.com

    Repligen Reports Second Quarter 2021 Financial Results and Updates Full Year 2021 Financial Guidance

    Reported revenue was $163.0 million for the quarter, representing year-over-year growth of 86% and organic growth of 69%Revenue guidance raised to…

  • Earnings Scheduled For July 27, 2021
    benzinga.com

    Earnings Scheduled For July 27, 2021

    Companies Reporting Before The Bell
    • Navios Maritime Partners (NYSE:NMM) is projected to report quarterly earnings at $2.93 per share on …

  • Nasdaq-listed Repligen to create 130 new jobs in Waterford
    irishtimes.com

    Nasdaq-listed Repligen to create 130 new jobs in Waterford

    Moves comes just nine months after company acquired Artseyn Biosolutions

  • Repligen Corp (RGEN): Price Up $2.97 (1.46)% Over Past Day, Up $0.53 (0.26)% Over Past Hour
    etfdailynews.com

  • Hedge Funds Are Piling Into Credicorp Ltd. (BAP)
    insidermonkey.com

    Hedge Funds Are Piling Into Credicorp Ltd. (BAP)

    After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms…

  • Lear Corporation (LEA) Fell Out Of Favor With Hedge Funds
    insidermonkey.com

    Lear Corporation (LEA) Fell Out Of Favor With Hedge Funds

    The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….

  • Where Do Hedge Funds Stand On Steel Dynamics, Inc. (STLD)?
    insidermonkey.com

    Where Do Hedge Funds Stand On Steel Dynamics, Inc. (STLD)?

    In this article you are going to find out whether hedge funds think Steel Dynamics, Inc. (NASDAQ:STLD) is a good investment right now. We like to check…

  • The New York Times Company Ranked Among Today’s Trending Stocks
    forbes.com

    The New York Times Company Ranked Among Today’s Trending Stocks

    Q.ai runs daily factor models to get the most up-to-date reading on stocks and ETFs. Today, our deep-learning algorithms have identified The New York Times Company among others.

  • Hollow Fiber Filtration Market worth $597 million by 2026 - Exclusive Report by MarketsandMarkets™
    markets.businessinsider.com

    Hollow Fiber Filtration Market worth $597 million by 2026 – Exclusive Report by MarketsandMarkets™

    CHICAGO, June 25, 2021 /PRNewswire/ — According to the new market research report 'Hollow Fiber Filtration Market by Material (Polymer (PES, PVDF…

  • 3 Stocks Growing Capex Fast
    gurufocus.com

    3 Stocks Growing Capex Fast

    GuruFocus Article or News written by Alberto Abaterusso and the topic is about: They have increased their investments in growth

  • Repligen inks an agreement to acquire (NASDAQ:RGEN)
    seekingalpha.com

    Repligen inks an agreement to acquire (NASDAQ:RGEN)

    Repligen Corporation (RGEN) agreed to acquire France-based Polymem, an industrial expert in developing and manufacturing hollow fiber membranes and modules.The products of Polymen are…

  • An Investing Truth: Roughly 80% Of Stocks Are “Duds”
    forbes.com

    An Investing Truth: Roughly 80% Of Stocks Are “Duds”

    Today I’m spilling the beans on something very important. It’s a “truth” about investing almost nobody understands.

  • The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
    benzinga.com

    The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges

    Here's a roundup of top developments in the biotech space over the last 24 hours.
    Scaling The Peaks
    (Biotech Stocks Hitting 52-week Highs Jan. 14) 10X …

  • Global Pharmaceutical Membrane Filtration Market (2020 to 2025) - Ultrafiltration Track-Etched Membranes Presents Opportunities
    benzinga.com

    Global Pharmaceutical Membrane Filtration Market (2020 to 2025) – Ultrafiltration Track-Etched Membranes Presents Opportunities

    Dublin, Jan. 15, 2021 (GLOBE NEWSWIRE) — The “Pharmaceutical Membrane Filtration Market by Product (Filter, System), Technique (Microfiltration, …

  • Stocks That Hit 52-Week Highs On Thursday
    benzinga.com

    Stocks That Hit 52-Week Highs On Thursday

    Before 10 a.m. ET Thursday, 503 stocks hit new 52-week highs.
    Noteworthy Points: Taiwan Semiconductor (NYSE:TSM) was the largest firm on a …

  • Here's Why You Should Really Own Repligen in 2021
    fool.com

    Here's Why You Should Really Own Repligen in 2021

    The tailwinds behind the company's gains aren't going anywhere.

  • Repligen Corporation To Present At 39th Annual J.P. Morgan Healthcare Conference
    thestreet.com

    Repligen Corporation To Present At 39th Annual J.P. Morgan Healthcare Conference

    WALTHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) — Repligen Corporation RGEN, a life sciences company focused on bioprocessing technology leadership, today

  • Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference
    benzinga.com

    Repligen Corporation to Present at 39th Annual J.P. Morgan Healthcare Conference

    WALTHAM, Mass., Jan. 04, 2021 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology …

  • Lykan Bioscience Welcomes Patrick Lucy As President And Chief Operating Officer
    thestreet.com

    Lykan Bioscience Welcomes Patrick Lucy As President And Chief Operating Officer

    HOPKINTON, Mass., Jan. 4, 2021 /PRNewswire/ — Lykan Bioscience, a contract Manufacturing Services Organization™ (MSO) and provider of the first true

  • Why Repligen Stock Soared 107% in 2020
    fool.com

    Why Repligen Stock Soared 107% in 2020

    The bioprocessing technology company gained momentum during the coronavirus pandemic.

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Repligen Aktie

Das Unternehmen Repligen Corporation aus USA beschäftigt 1.393 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.

Das Unternehmen Repligen Corporation ist nur in 6 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter iShares  MSCI USA  Small Cap  UCITS  ETF gewichtet Repligen mit 0,26% im ETF.

6 ETFs die in Repligen investieren

Dir gefallen die Informationen zu Repligen?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Repligen?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba

Dir gefallen die Informationen zu Repligen?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Repligen?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect